Strategic Partners A/S (CPSE: STRAP)
Health Care · Biotechnology · DK
Dkr655.00
-2.96% today · -24.2% 1Y
Strategic Partners A/S (CPSE: STRAP) operates in the Biotechnology industry within the Health Care sector. The company is valued at $4.11M and employs 1 people.
Over the last twelve months the share price has lost 24.2%, trading between 515.00 and 946.00.
Tweenvest scores Strategic Partners A/S across four factors: quality 44/100, value 58/100. Its strongest factor is value.
STRAP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.11M
- Revenue (TTM)
- $46.45K
- P/E
- 20.56
- EPS
- 31.86
- Dividend yield
- —
- Beta (5Y)
- 0.24
- 52-week high
- Dkr946.00
- 52-week low
- Dkr515.00
- Avg volume (3M)
- —
- Shares outstanding
- 41.71K
- Employees
- 1
- Next earnings
- —
About Strategic Partners A/S
Strategic Partners A/S currently conducts minimal business operations. Its previous activities centered on the field of biotechnology. The firm, originally known as Orphazyme A/S, adopted the new moniker Strategic Partners A/S in October 2024. Established in 2009, the company's base of operations is situated in Herlev, Denmark.
- ISIN
- DK0062502894
- Founded
- 2009
- Listed since
- Nov 21, 2017
- Exchange
- OMX Nordic Exchange Copenhagen
- Currency
- DKK
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Azitra, Inc.NYSEAM: AZTR | $4.33M | $0.07 | -44.96% |
| Kane Biotech Inc.TSXV: KNE | $4.33M | CA$0.03 | -16.67% |
| NuCana plcNasdaqCM: NCNA | $4.27M | $0.99 | -9.99% |
| Telo Genomics Corp.TSXV: TELO | $4.26M | CA$0.06 | -14.29% |
| Medicus Pharma Ltd.NasdaqCM: MDCX | $4.11M | $3.25 | 0.00% |
| Liminatus Pharma, Inc.NasdaqCM: LIMN | $4.08M | $3.04 | -19.15% |
| Enlivex Ltd.NasdaqCM: ENLV | $4.08M | $0.21 | -19.29% |
| Biotron LimitedASX: BIT | $3.88M | AU$0.00 | -20.00% |
Figures last refreshed Oct 18, 2026.